The role of melatonin in acute myocardial infarction

Frontiers in Bioscience

Volumn 17, Issue 7, 2011, Pages 2433-2441

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Avanzas, Pablo ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Acute myocardial infarction; Antioxidant; Ischemia reperfusion; Melatonin; Review

Indexed keywords

EID: 84860284267     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4063     Document Type: Article

References (70)

1. AD Lopez, CC Murray: The global burden of disease: 1990-2020. Nat Med 4, 1241-1243 (1998)
2. MA DeWood, J Spores, R Notske, LT Mouser, R Burroughs, MS Golden, HT Lang: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction: N Engl J Med 303, 897-902 (1980) (Pubitemid 10021186)
3. KA Reimer, JE Lowe, MM Rasmussen, RB Jennings: The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56, 786-794 (1977) (Pubitemid 8235183)
4. AL Moens, MJ Claeys, JP Timmermans, CJ Vrints: Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100, 179-190 (2005)
5. JL Zweier: Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 263, 1353-1357 (1988) (Pubitemid 18039938)
6. WW Brooks, CH Conrad, JP Morgan: Reperfusion induced arrhythmias following ischaemia in intact rat heart: role of intracellular calcium. Cardiovasc Res 29, 536-542 (1995)
7. LA Neves, AP Almeida, MC Khosla, MJ Campagnole-Santos, RA Santos: Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Braz J Med Biol Res 30, 801-809 (1997) (Pubitemid 127519600)
8. PR Hansen: Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91, 1872-1885 (1995)
9. CY Xiao, A Hara, K Yuhki, T Fujino, H Ma, Y Okada, O Takahata, T Yamada, T Murata, S Narumiya, F Ushikubi: Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation 104, 2210-2215 (2001) (Pubitemid 33043302)
10. RJ Reiter, DX Tan: Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58, 10-19 (2003) (Pubitemid 36351618)
11. S Tengattini, RJ Reiter, DX Tan, MP Terron, LF Rodella, R Rezzani: Cardiovascular diseases: protective effects of melatonin. J Pineal Res 44, 16-25 (2008) (Pubitemid 350231106)
12. A Dominguez-Rodriguez, P Abreu-Gonzalez, RJ Reiter: Clinical aspects of melatonin in the acute coronary syndrome. Curr Vasc Pharmacol 7, 367-373 (2009)
13. A Dominguez-Rodriguez, P Abreu-Gonzalez, JJ Sanchez-Sanchez, JC Kaski, RJ Reiter: Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 49, 14-22 (2010)
14. RJ Reiter RJ: Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 12, 151-180 (1991)
15. RJ Reiter: Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79, C153-C158 (1991)
16. FW Turek, C Dugovic, PC Zee: Current understanding of the circadian clock and the clinical implications for neurological disorders. Arch Neurol 58, 1781-1787 (2001) (Pubitemid 33044243)
17. RY Moore: Neural control of the pineal gland. Behav Brain Res 73, 125-130 (2001) (Pubitemid 26008772)
18. DX Tan, LC Manchester, MP Terron, LJ Flores, RJ Reiter: One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42, 28-42 (2007) (Pubitemid 44924323)
19. P Brugger, W Marktl, M Herold: Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 345, 1408 (1995)
20. A Sakotnik, PM Liebmann, K Stoschitzky, P Lercher, K Schauenstein, W Klein, B Eber: Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 20, 1314-1347 (1999)
21. L Girotti, M Lago, O Ianovsky, J Carbajales, MV Elizari, LI Brusco, DP Cardinali: Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J Pineal Res 29, 138-142 (2000)
22. K Vijayasarathy, K Shanthi Naidu, BK Sastry: Melatonin metabolite 6-Sulfatoxymelatonin, Cu/Zn superoxide dismutase, oxidized LDL and malondialdehyde in unstable angina. Int J Cardiol 144, 315-317 (2010)
23. M Yaprak, A Altun, A Vardar, M Aktoz, S Ciftci, G Ozbay: Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol 89, 103-107 (2003) (Pubitemid 36513876)
24. A Altun, M Yaprak, M Aktoz, A Vardar, UA Betul, G Ozbay: Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci Lett 327, 143-145 (2002) (Pubitemid 34722427)
25. A Dominguez-Rodríguez, P Abreu-Gonzalez, MJ Garcia, J Sanchez, F Marrero, D de Armas-Trujillo: Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 33, 248-252 (2002) (Pubitemid 35252997)
26. W Koenig, N Khuseyinova: Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 27, 15-26 (2007) (Pubitemid 46360377)
27. A Dominguez-Rodriguez, P Abreu-Gonzalez, M Garcia, J Ferrer, A de la Rosa, M Vargas, RJ Reiter: Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine 26, 89-93 (2004) (Pubitemid 38410888)
28. A Dominguez-Rodriguez, M Garcia-Gonzalez, P Abreu-Gonzalez, J Ferrer, JC Kaski: Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97, 10-12 (2006) (Pubitemid 41828113)
29. A Dominguez-Rodriguez, P Abreu-Gonzalez, MJ Garcia-Gonzalez, RJ Reiter: Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction. Thromb Res 120, 361-366 (2007) (Pubitemid 46879902)
30. A Dominguez-Rodriguez, P Abreu-Gonzalez, MJ Garcia-Gonzalez, S Samimi-Fard, JC Kaski, RJ Reiter: Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with STsegment elevation myocardial infarction. J Pineal Res 44, 65-69 (2008) (Pubitemid 350231111)
31. RJ Reiter, JR Calvo, M Karbownik, W Qi, DX Tan: Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917, 376-386 (2000)
32. A Dominguez-Rodriguez, P Abreu-Gonzalez, M Garcia-Gonzalez, RJ Reiter: Prognostic value of nocturnal melatonin levels as a novel marker in patients with STsegment elevation myocardial infarction. Am J Cardiol 97, 1162-1164 (2006)
33. A Dominguez-Rodriguez, P Abreu-Gonzalez P: Myocardial ischemia-reperfusion injury: Possible role of melatonin. World J Cardiol 2, 233-236 (2010)
34. T Béard, D Carrié, MJ Boyer, B Boudjemaa, J Ferrières, M Delay, P Bernadet, JP Thouvenot: Production of oxygen free radicals in myocardial infarction treated by thrombolysis. Analysis of glutathione peroxidase, superoxide dismutase and malondialdehyde]. Arch Mal Coeur Vaiss 87, 1289-1296 (1994) (Pubitemid 24338835)
35. MJ Roberts, IS Young, TG Trouton, ER Trimble, MM Khan, SW Webb, CM Wilson, GC Patterson, AA Adgey: Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 336, 143-145 (1990) (Pubitemid 20224975)
36. YM Lee, HR Chen, G Hsiao, JR Sheu, JJ Wang, MH Yen: Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 33, 72-80 (2002) (Pubitemid 34913483)
37. A Lochner, S Genade, A Davids, K Ytrehus, JA Moolman: Short-and long-term effects of melatonin on myocardial post-ischemic recovery. J Pineal Res 40, 56-63 (2006)
38. P Sallinen, S Mänttäri, H Leskinen, M Ilves, O Vakkuri, H Ruskoaho, S Saarela: The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin. J Pineal Res 42, 254-260 (2007) (Pubitemid 46365062)
39. PC Redondo, GM Salido, JA Rosado, JA Pariente: Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem Pharmacol 67, 491-502 (2004) (Pubitemid 38232889)
40. N Alexandru, I Jardín, D Popov, M Simionescu, J García-Estaño, GM Salido, JA Rosado: Effect of homocysteine on calcium mobilization and platelet function in type 2 diabetes mellitus. J Cell Mol Med 12, 2015-2026 (2008)
41. L Di Bella, L Gualano: Key aspects of melatonin physiology: thirty years of research. Neuro Endocrinol Lett 27, 425-432 (2006) (Pubitemid 46043597)
42. AL Morera, P Abreu: Existence of melatonin in human platelets. J Pineal Res 39, 432-433 (2005)
43. A Dominguez-Rodriguez, P Abreu-Gonzalez, A Jimenez-Sosa, P Avanzas, F Bosa-Ojeda, JC Kaski: Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 106, 1540-1544 (2010)
44. Y Xu, Y Huo, MC Toufektsian, SI Ramos, Y Ma, AD Tejani, BA French, Z Yang: Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 290, H692-H699 (2006)
45. A Dominguez-Rodriguez, P Abreu-Gonzalez, MJ Garcia-Gonzalez, S Samimi-Fard, RJ Reiter, JC Kaski: Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 199, 73-78 (2008) (Pubitemid 351842702)
46. M Crompton: Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 529, 11-21 (2000)
47. AP Halestrap: Mitochondria and preconditioning: a connexin connection? Circ Res 99, 10-12 (2006) (Pubitemid 44297049)
48. DJ Hausenloy, DM Yellon: The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 35, 339-341 (2003) (Pubitemid 36411694)
49. AP Halestrap, SJ Clarke, SA Javadov: Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 61, 372-385 (2004) (Pubitemid 38210145)
50. J Leon, D Acuña-Castroviejo, G Escames, DX Tan, RJ Reiter: Melatonin mitigates mitochondrial malfunction. J Pineal Res 38, 1-9 (2005) (Pubitemid 40139304)
51. G Petrosillo, G Colantuono, N Moro, FM Ruggiero, E Tiravanti, N Di Venosa, T Fiore, G Paradies: Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 297, H1487-H1493 (2009)
52. ML Dubocovich, K Markowska: Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27, 101-110 (2005) (Pubitemid 41558442)
53. C Ekmekcioglu, P Haslmayer, C Philipp, MR Mehrabi, HD Glogar, M Grimm, T Thalhammer, W Marktl: 24h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease. Chronobiol Int 18, 973-985 (2001) (Pubitemid 34020045)
54. C Ekmekcioglu, T Thalhammer, S Humpeler, MR Mehrabi, HD Glogar, T Hölzenbein, O Markovic, VJ Leibetseder, G Strauss-Blasche, W Marktl: The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 35, 40-44 (2003) (Pubitemid 36819169)
55. R Jockers, P Maurice, JA Boutin, P Delagrange: Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol 154, 1182-1195 (2008) (Pubitemid 351992057)
56. S Samimi-Fard, P Abreu-Gonzalez, A Dominguez-Rodriguez, A Jimenez-Sosa: A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population. J Pineal Research 51, 400-404 (2011)
57. O Szárszoi, G Asemu, J Vanecek, B Ost'ádal, F Kolár: Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 15, 251-257 (2001) (Pubitemid 33010608)
58. E Sahna, A Acet, MK Ozer, E Olmez: Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin. J Pineal Res 33, 234-238 (2002) (Pubitemid 35252995)
59. E Sahna, H Parlakpinar, MK Ozer, F Ozturk, F Ozugurlu, A Acet: Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J Pineal Res 35, 257-261 (2003) (Pubitemid 37338859)
60. P Dobsak, J Siegelova, JC Eicher, J Jancik, H Svacinova, J Vasku, S Kuchtickova, M Horky, JE Wolf: Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart. Pathophysiology 9, 179-187 (2003) (Pubitemid 37309298)
61. A Kaçmaz, EY User, AO Sehirli, M Tilki, S Ozkan, G Sener: Protective effect of melatonin against ischemia/reperfusion-induced oxidative remote organ injury in the rat. Surg Today 35, 744-750 (2005) (Pubitemid 41199877)
62. S Genade, K Ytrehus, A Lochner: Melatonin prevent cardioprotection induced by a multi-cycle ischaemic preconditioning protocol in the isolated perfused rat heart. Cardiovasc J S Afr 17, 239-244 (2006) (Pubitemid 46089126)
63. A Dominguez-Rodriguez, P Abreu-Gonzalez, MJ Garcia-GonzalezJ, JC Kaski, RJ Reiter, A Jimenez-Sosa: A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials 28, 532-539 (2007) (Pubitemid 46755019)
64. A Dominguez-Rodriguez, P Abreu-Gonzalez: Melatonin: Still a forgotten antioxidant. Int J Cardiol 149, 382 (2011)
65. A Korkmaz, RJ Reiter, T Topal, LC Manchester, S Oter, DX Tan: Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15, 43-50 (2009)
66. RJ Reiter, F Gultekin, LJ Flores, MP Terron, DX Tan: Melatonin: potencial utility for improving public health. TAF Prev Med Bull 5, 131-158 (2006)
67. Z Chen, CC Chua, J Gao, RC Hamdy, BH Chua: Protective effect of melatonin on myocardial infarction. Am J Physiol Heart Circ Physiol 284, H1618-H1624 (2003) (Pubitemid 36460774)
68. MLV Seabra, M Bignotto, LR Pinto, S Tufik: Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 29, 193-200 (2000)
69. PD Penev, PC Zee: Melatonin: A clinical perspective. Ann Neurol 42, 545-553 (1997) (Pubitemid 27439016)
70. J Leon, G Escames, MI Rodríguez, LC López, V Tapias, A Entrena, E Camacho, MD Carrión, MA Gallo, A Espinosa DX, Tan, RJ Reiter, D Acuña-Castroviejo: Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 98, 2023-2033 (2006) (Pubitemid 44298263)